suicide

#’Startling’ Increase in #Alcohol-Induced Deaths Requires ‘Urgent Action’

Postado em

Rates of alcohol-induced deaths in the United States have increased substantially over the past 17 years among men and women across all racial/ethnic groups, with more rapid increases in recent years, a new analysis shows.

These deaths are “an urgent public health crisis calling for concerted public health action,” study investigator Susan Spillane, PhD, of the National Cancer Institute’s Division of Cancer Epidemiology and Genetics, Rockville, Maryland, told Medscape Medical News.

The increases are particularly concerning, especially inasmuch as they affect many segments of the population, including young people, she added. It is also “striking” that the observed increases were largest in more recent years.

The study was published online February 21 in JAMA Network Open.

National Data

Using national vital statistics data, the researchers examined how rates of alcohol-induced deaths changed in the United States from 2000 to 2016.

Alcohol-induced deaths were defined as deaths due to alcohol consumption that could be avoided if alcohol weren’t involved. They include, but are not limited to, alcoholic liver disease, alcohol-induced acute or chronic pancreatitis, alcohol-related mental and behavioral disorders, alcoholic cardiomyopathy, and alcohol poisoning.

From 2000 to 2016, 425,045 alcohol-induced deaths occurred. In 2000, there were 19,627 deaths (76% men). By 2016, the number was 34,857 (73% men).

On average, rates of alcohol-induced deaths per year rose 1.4% in men and 3.1% in women and accelerated in recent years: 4.2% per year in men from 2012 to 2016, and 7.1% per year in women from 2013 to 2016.

The largest increases by race/ethnicity were observed among American Indian and Alaska Native (AIAN) men and women and white women, but increases throughout the study period were also noted for Asian and Pacific Islander (API) men and women and Latina women.

Despite an initial decline among black women from 2000 to 2007, black men from 2000 to 2012, and Latino men from 2000 to 2013, these “promising” trends reversed course, and rates of alcohol-induced deaths increased from 2013 to 2016 in all examined racial/ethnic groups, the authors report.

In keeping with previous trends, the researchers found large absolute increases in alcohol-induced deaths among white individuals during midlife, particularly among men.

“However, the steepest increases in the rates of alcohol-induced deaths among white individuals in our study population occurred among younger adults, particularly women,” they note.

Among people aged 25 to 34 years, alcohol-induced deaths ranged from 4.6% to 6.9% per year among men and from 7.3% to 12.0% per year among women.

Call to Arms

As previously reported by Medscape Medical News, the US Preventive Services Task Force recently recommended screening for unhealthy alcohol use among adults in primary care settings as well as providing behavioral counseling interventions.

The findings in this analysis “justify the authors’ call to arms to address alcohol-related morbidity and mortality of this long-recognized yet growing public health crisis among Native people and other segments of the US population,” Spero Manson, PhD, with the Centers for American Indian and Alaska Native Health, University of Colorado Anschutz Medical Campus in Aurora, writes in a linked commentary in JAMA Network Open.

He notes it’s also important to realize that alcohol-induced deaths are just the “tip of the iceberg.”

“Alcohol-related deaths — notably suicide, motor vehicle collisions, drowning, and homicide — remain high among AIAN individuals and continue to rise. Combined, they underscore the urgency of the authors’ call to action,” Manson writes.

“Recent concerns about the opioid epidemic sweeping through AIAN populations are well founded and demand immediate attention. However, attendant shifts in funding and programming emphases threaten to overshadow the continued, growing crisis of alcohol use and dependence in this population. We forget this peril at great risk to the future of Native peoples,” he concludes.

Funding for the study was provided by a grant from the Health Research Board of Ireland and by the Cancer Prevention Fellowship Program within the Intramural Research Program of the National Cancer Institute. Spillane and Manson have disclosed no relevant financial relationships.

JAMA Netw Open. Published online February 21, 2020. Full text,

#Suicide : la stratégie de prévention régionale se renforce

Postado em

Paris, France — A l’occasion de la Journée Mondiale de la Prévention du suicide du 10 septembre 2019, la Direction Générale de la Santé (DGS) revient sur la stratégie de prévention régionale en cours de déploiement en France.

Elle rappelle, dans un communiqué[1], qu’en France, le taux de décès par suicide est de 13,7 pour 100 000 habitants, un des taux les plus élevés en Europe, derrière les pays de l’Est, la Finlande et la Belgique et que « le taux de suicide est variable selon les régions voire les territoires, le taux allant dans les départements de 6,2 à 22,6 décès par suicide pour 100 000 habitants, ce qui permet d’alerter sur la situation de certains d’entre eux ».

Le développement de la stratégie régionale de prévention est inscrit dans la feuille de route « Santé mentale et psychiatrie » avec pour objectif « de mieux repérer et de maintenir le lien avec les personnes à risque suicidaire au plus près de leur lieu de vie ». Elle prévoit notamment de mettre à disposition des agences régionales de santé (ARS) un ensemble d’actions intégrées de prévention du suicide.

Trois actions phares

En tout, trois actions phares sont en cours de déploiement au niveau régional.

La première cible est le maintien du contact avec les personnes ayant fait une tentative de suicide grâce au dispositif VigilanS consistant à recontacter des personnes ayant fait une tentative de suicide. Ce dispositif de veille des suicidants sur une période de 6 mois est opérationnel dans cinq régions, et sera étendu à l’ensemble du territoire d’ici 2021.

En 2019, 5,8 millions d’euros ont été mobilisés pour son financement, et le suivi a concerné 8 353 patients depuis le début de l’année, précise la DGS.

La seconde action concerne la formation actualisée au repérage, à l’évaluation et à l’intervention auprès des personnes à risque suicidaire. « Elle est adaptée aux rôles et aux compétences des personnes formées (professionnels de santé et citoyens volontaires) pour créer un réseau de personnes ressources dans chaque région », souligne la DGS ;

Enfin, des actions ciblées sont développées pour lutter contre le risque de contagion suicidaire. Les personnes exposées directement ou indirectement à un événement suicidaire sont elles-mêmes plus à risque. Il en découle la survenue « d’épidémies » localisées (hôpitaux, entreprises, écoles, ponts, falaises, forêts, etc.) ou sur tout le territoire sous l’influence des médias ou des réseaux sociaux.

Dans ce troisième volet de mesures, il est notamment prévu le soutien au programme national Papageno, qui met en œuvre des solutions innovantes pour tous ceux qui souhaitent s’engager dans la prévention de la contagion suicidaire (centre ressource, modules de formation pour les professionnels de santé, les journalistes…).

L’ensemble de ces actions s’intègrent dans les travaux engagés tant dans les projets territoriaux de santé mentale (PTSM) que dans d’autres outils au service de la politique de santé mentale au niveau local (conseils locaux de santé mentale ou contrats locaux de santé), indique la DGS.

 

 

 

 

 

 

#Bariatric surgery tied to risks for #suicide and #non-fatal self-harm

Postado em

  • The Lancet Diabetology

Background

Bariatric surgery reduces mortality, but might have adverse effects on mental health. We assessed the risk of suicide and self-harm after bariatric surgery compared with non-surgical obesity treatment.

Methods

Suicide and non-fatal self-harm events retrieved from nationwide Swedish registers were examined in two cohorts. The non-randomised, prospective Swedish Obese Subjects (SOS) study compared bariatric surgery (n=2010; 1369 vertical-banded gastroplasty, 376 gastric banding, and 265 gastric bypass) with usual care (n=2037; recruitment 1987–2001). The second cohort consisted of individuals from the Scandinavian Obesity Surgery Registry (SOReg; n=20 256 patients who had gastric bypass) matched to individuals treated with intensive lifestyle modification (n=16 162; intervention 2006–13) on baseline BMI, age, sex, education level, diabetes, cardiovascular disease, history of self-harm, substance misuse, antidepressant use, anxiolytics use, and psychiatric health-care contacts.

Findings

During 68 528 person-years (median 18; IQR 14–21) in the SOS study, suicides or non-fatal self-harm events were higher in the surgery group (n=87) than in the control group (n=49; adjusted hazard ratio [aHR] 1.78, 95% CI 1.23–2.57; p=0.0021); of these events, nine and three were suicides, respectively (3.06, 0.79–11.88; p=0.11). In analyses by primary procedure type, increased risk of suicide or non-fatal self-harm was identified for gastric bypass (3.48, 1.65–7.31; p=0∙0010), gastric banding (2.43, 1.23–4.82; p=0.011), and vertical-banded gastroplasty (2.25, 1.37–3.71; p=0.0015) compared with controls. Out of nine deaths by suicide in the SOS surgery group, five occurred after gastric bypass (two primary and three converted procedures). During 149 582 person-years (median 3.9; IQR 2.8–5.2), more suicides or non-fatal self-harm events were reported in the SOReg gastric bypass group (n=341) than in the intensive lifestyle group (n=84; aHR 3.16, 2.46–4.06; p<0.0001); of these events, 33 and five were suicides, respectively (5.17, 1.86–14.37; p=0.0017). In SOS, substance misuse during follow-up was recorded in 48% (39/81) of patients treated with surgery and 28% (13/47) of controls with non-fatal self-harm events (p=0∙023). Correspondingly, substance misuse during follow-up was recorded in 51% (162/316) of participants in the SOReg gastric bypass group and 29% (23/80) of participants in the intensive lifestyle group with non-fatal self-harm events (p=0∙0003). The risk of suicide and self-harm was not associated with poor weight loss outcome.

Interpretation

Bariatric surgery was associated with suicide and non-fatal self-harm. However, the absolute risks were low and do not justify a general discouragement of bariatric surgery. The findings indicate a need for thorough preoperative psychiatric history assessment along with provision of information about increased risk of self-harm following surgery. Moreover, the findings call for postoperative surveillance with particular attention to mental health.

Funding

US National Institutes of Health and Swedish Research Council.

#Oral Contraceptives Linked to #Suicide

Postado em

Megan Brooks

Women who use hormonal contraceptives are at increased risk for suicide attempt and suicide. The highest relative risk is seen in adolescent women, a large Danish study indicates.

“Women should be aware of this potential adverse effect of hormonal contraception so that they might consider alternatives if they develop depression after starting use of hormonal contraception,” Øjvind Lidegaard, MD, Department of Gynecology, Rigshospitalet, Copenhagen, and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark, told Medscape Medical News.

“Doctors should be a little more careful when they prescribe hormonal contraception to ensure that the woman doesn’t have an actual depression or have been treated for depression and/or suicide attempts previously,” added Dr Lidegaard.

The study was published online November 17 in the American Journal of Psychiatry.

Heightened Early Risk

In a previous Danish nationwide prospective cohort study in women and female adolescents, the researchers found an association between use of hormonal contraception and depression, as reported by Medscape Medical News. The association was most pronounced among adolescents.

In the current study, the investigators followed a complete national cohort of women aged 15 years and older to assess daily use of hormonal contraception and the risk for a subsequent first suicide attempt or suicide.

Exclusion criteria included prior suicide attempts, antidepressant use, psychiatric diagnosis, cancer diagnosis, or venous thrombosis diagnosis, because these factors could influence both use of hormonal contraception and risk for suicide.

Nearly half a million women were followed on average for 8.3 years (3.9 million person-years). The mean age of the participants was 21 years; 6999 first suicide attempts and 71 suicides were identified. The relative risk for first suicide attempt and suicide was found to be increased among those who currently used hormonal contraceptives or who had used them recently, in comparison with women who had never used them.

Table 1.

Event Relative Risk 95% CI
Suicide attempt 1.97 1.85 – 2.01
Suicide 3.08 1.34 – 7.08

 

Adolescents were more sensitive than older women to the influence of hormonal contraception on risk for first suicide attempt.

Table 2.

Age (Years) Relative Risk 95% CI
15 – 19 2.06 1.92 – 2.21
20 – 24 1.61 1.39 – 1.85
25 – 33 1.64 1.14 – 2.36

 

The risk for suicide attempt varied by type of hormonal contraception. Relative risk estimates were 1.91 (95% confidence inverval [CI], 1.79 – 2.03) for oral combined products, 2.29 (95% CI, 1.77 – 2.95) for oral progestin-only products, 2.58 (95% CI, 2.06 – 3.22) for vaginal ring, and 3.28 (95% CI, 2.08 – 5.16) for the patch.

The association between hormonal contraceptive use and a first suicide attempt peaked after 2 months of use; a decreasing trend was noted after 1 year of use.

“The decrease in risk estimates for suicide attempt after 1 year of use was probably due to out-selection of women who develop adverse mood reactions after initiation of hormonal contraception,” the researchers write.

Five studies have assessed suicide attempts and suicides in users of hormonal contraception. All five found elevated risks, although such elevations were statistically significant in only one of the studies. “Note that none of the previous studies included young women between 15 and 25 years, which according to our study is the most vulnerable group of women when exposed to hormonal contraception,” Dr Lidegaard told Medscape Medical News.

“More awareness of possible mood implications from exogenous female sex hormones is warranted,” the researchers conclude in their article. “Considering the severity of these little-recognized potential side effects of hormonal contraceptives, health professionals and women starting hormonal contraceptives should be informed about them,” they write.

“Suicidal attempts and suicides should be added to the list of potential adverse effects with use of hormonal contraception. It is a good idea to make a control visit to a gynecologist about 3 months after starting on hormonal contraception in order to ensure good compliance with the new method and to ask into their mental health,” said Dr Lidegaard.

Don’t Prescribe Lightly

Commenting on the findings for Medscape Medical News, Seth Mandel, MD, chairman of psychiatry at Northwell Health’s Huntington Hospital in New York, said that in his clinical practice, which largely focuses on late adolescent and young adult women with borderline personality disorder, it is not uncommon for patients to report a worsening of depressive symptoms after starting treatment with oral contraceptive pills (OCPs).

“This study goes one step further and reports that women with ostensibly no psychiatric illness also experienced suicidality. As the study also points out, adolescent women already have other risk factors for suicidal behavior and may account for why they are more strongly affected,” he said.

“Healthcare professionals need to keep in mind the possible unmasking or causation of suicidality in women started on OCPs,” Dr Mandel said. “These are hormones and are not to be prescribed lightly. Women should be well informed of the possible risks and also educated regarding all the other options that exist for contraception. These medications are useful for other medical conditions, and we must remain vigilant in all patients prescribed OCPs.”

Dr Mandel said it is also worth noting that mifepristone (multiple brands) is a very active antiprogesterone and antiglucocorticosteroid agent. The drug “initially showed potential benefits in psychotic depression and is being studied for bipolar depression. The disturbance of the stress hormone system (the hypothalamic-pituitary-adrenal, or HPA, axis) may make the depressive symptoms worse. If such a medication can be used to treat depression, it is not surprising that an OCP, which has many of the opposite effects, could cause it.”

The study was supported by the Lundbeck Foundation and the Department of Gynecology, Rigshospitalet, University of Copenhagen. Dr Lidegaard has received speaking honoraria from Exeltis.

Am J Psychiatry. Published online November 17, 2017. Abstract

#Machine Learning, #MRI #Accurately Identify Suicidal Intent

Postado em

Pauline Anderson

Machine learning combined with fMRI accurately identifies young adults with suicidal thoughts, new research shows.

Using fMRI and computer-generated algorithms to measure the brain’s response to death, suicide, and other concepts, researchers reliably distinguished youth with suicidal thoughts from control persons and accurately identified individuals who had made a suicide attempt.

This is important because most people do not report suicidal feelings. Research shows that almost 80% of patients who die by suicide denied they had suicidal thoughts during their last contact with a mental healthcare professional.

“The biological processes that are involved in suicidal thinking and behavior reflect changes in the way people feel and think about related concepts,” study author David Brent, MD, a child and adolescent psychiatrist and professor of psychiatry, University of Pittsburgh Medical Center and School of Medicine, told Medscape Medical News.

Dr David Brent

“This approach gives us hope that we will be able to more precisely target those issues and be able to help more people.”

The study was published online October 30 in Nature Human Behavior.

Machine Learning Classifier

The study included 17 patients with suicidal thoughts, many of whom had been recently discharged from an inpatient facility, and 17 healthy volunteers who had no personal or family history of psychiatric disorder or suicide attempts.

The groups were matched with respect to intelligence, sex ratio (24% male) and age (mean age, about 22 years).

The researchers assessed history of suicide attempt with the Suicide History Form and Suicide Intent Scale. They assessed severity of suicidal ideation using the interviewer-rated Columbia-Suicide Severity Rating Scale (C-SSRS) and the self-reported Adult Suicide Ideation Questionnaire (ASIQ).

While the participants were exposed to various stimuli, researchers used fMRI to view various brain regions.

The stimuli included three word groups, each of which had 10 words. The word groups were related to suicide, negative affect, and positive affect.

The 30 stimulus items were presented six times in random order. Each item was displayed for 3 seconds. The 3-second display was followed by a four-second interval, and longer intervals were included periodically.

Participants were asked to actively think about the concepts to which the stimulus words referred.

A psychiatrist was present during testing of the patients with suicidal ideation “to ensure they were safe when they were invited to think about these things,” said Dr Brent.

The researchers distinghished the groups through the use of computer-generated algorithms.

“When you’re looking at patterns of brain activation, you’re talking about a huge amount of data,” said Dr Brent. “So in order to separate the responses and classify them, you can’t use conventional methods very effectively.”

The machine-learning classifier identified suicidal individuals with a very high accuracy rate (0.90; P < .000001), correctly identifying 15 of the 17 suicidal participants and 16 of the 17 control persons (sensitivity = 0.88, specificity = 0.94, positive predictive value [PPV] = 0.94, negative predictive value [NPV] = 0.89).

Key Brain Regions

The investigators found that the high degree of accuracy in classification remained after statistically controlling for group differences, such as variations in anxiety and history of childhood trauma.

The concepts that most strongly distinguished the groups were death, cruelty, trouble, carefree, good, and praise.

The most discriminating brain regions included the left superior medial frontal area, the medial frontal/anterior cingulate, the right middle temporal area, the left inferior parietal area, and the left inferior frontal area. All these regions have repeatedly been strongly associated with self-referential thought.

“It seemed to indicate that if you gave a word like ‘suicide’ or ‘death,’ the ideators would think about ‘my death,’ whereas the controls would just think of the concepts of death without necessarily thinking of themselves,” said Dr Brent.

For individuals with suicidal thoughts, there also appeared to be some disconnection in prefrontal activation, said Dr Brent.

“When healthy people experience a negative thought or a negative emotion, they are able to effectively redirect it by activating parts of the prefontal cortex to modify things. We didn’t see that to the same extent in the people who were suicidal.”

An intervention such as cognitive-behavioral therapy may help change the way a patient thinks about these concepts, said Dr Brent.

He noted that researchers have developed a game that conditions people to associate “self” with positive thoughts and words related to “suicide” with negative thoughts. Use of this game has resulted in decreased self-harm and suicidal behavior, he said.

“So you may be able to try to help people uncouple things that are driving them towards unhealthy conclusions and behavior.”

The machine-learning approach could also identify when patients are improving and are becoming less fixated on suicide. “In that way, it could also have a therapeutic benefit,” said Dr. Brent.

Neural Signatures

The authors noted that the six concepts that were altered in those with suicidal ideation include items from all three stimulus categories ― one related to suicide, two negative concepts, and three positive concepts.

“The valuation of what is important and good in life and what is not seems to be altered in ideators,” the authors write. “Our results provide a neurally based, quantitative measure of this alteration.”

In previous research, the study’s lead author, Marcel Adam Just, PhD, DO Hebb Professor, Department of Psychiatry, Carnegie Mellop University, Pittsburgh, identified the neural “signatures” of different emotions.

Using those algorithms, he and his colleagues identified the “signatures” for “sadness,” “shame,” “anger,” and “pride” within the neural representations of the six concepts.

In the group with suicidal ideation, the concept of “death” evoked more shame than in the control group, whereas the concept of “trouble” evoked more sadness. In addition, “trouble” evoked less anger and the positive concept “carefree” evoked less pride in the group with suicidal ideation.

This type of neurally acquired information may provide specific targets for intervention. For example, said Dr Brent, if a suicidal patient is feeling a lot of shame, a psychotherapist could talk about this with the patient.

“It may give us a sense of things that are driving people toward suicide that they may or may not be able to express explicitly.”

Within the suicidal ideation group, the machine-learning classifier was able to distinguish the nine patients who had made a suicide attempt from participants who had not attempted suicide.

The concepts that best discriminated between those who attempted suicide and those who did not were “death,” “lifeless,” and “carefree.” These terms include two suicide-related concepts and one positive concept. The most discriminating brain regions here were the left superior medial frontal area, the medial frontal/anterior cingulate, and the right middle temporal area.

“Fascinating” Finding

There were also differences in emotional signatures between those who had attempted suicide and those who had not. For example, the concept of death evoked less sadness in those who attempted suicide.

“We speculate that for those who are conflicted about engaging in a suicidal act, the thought of facilitating death is shameful, whereas those ideators who have made an attempt show greater attraction to and acceptance of death, and hence less sadness in thinking about it,” the authors note.

The ability of the machine-learning approach to identify people who had attempted suicide and the fact that they had a different emotional experience than those with suicidal thoughts who had not made an attempt were “the most fascinating” aspects of the study.

Again, this may point to some therapeutic possibilities, he said.

The researchers did not investigate sex differences in patterns of thinking when exposed to the various concepts.

Dr Brent acknowledged that some suicidal patients may not want others to know what they are planning and so might simply block out thoughts that would give away their intentions.

At present, it is not practical to use fMRI clinically to identify patients with suicidal ideation. But Dr Brent and his colleagues hope to eventually develop a simple computer task or screening test to identify people at risk.

Dr Just is investigating the use of EEG instead of fMRI, which would be less expensive and more widely accessible.

Other researchers are using machine-learning and data from electronic health records to identify patients who are at risk of attempting suicide within the following 7-day period, said Dr Brent

He noted that using machine-learning of neural representations of suicide is “not a silver bullet.” He described the new research as “proof of concept.”

“It’s a way of opening a window into how people think, and possible mechanisms, but in terms of public health ways of identification, I think that screening either though electronic health record or other kinds of self-report, or through computer tasks, will be a much more efficient way to go.”

Pioneering Research

Commenting on the study for Medscape Medical News, E. David Klonsky, PhD, professor, Department of Psychology, University of British Columbia, Vancouver, Canada, whose research interests include suicide, described it as “fascinating” and “pioneering.”

“It combines two promising technologies ― machine learning and brain imaging ― to advanced knowledge about suicide risk and prediction.”

However, said Dr Klonsky, like many studies of new approaches, there are considerable obstacles to applying these methods to improve risk detection and prevention.

For example, he said, in real-world clinical settings, most patients have depression or another psychiatric disorder, and health professionals try to identify those at heightened risk for suicide “above and beyond their psychiatric diagnosis.”

But this study compared individuals with suicidal ideation to healthy control persons who had no history of suicidal ideation and no personal or family history of a psychiatric disorder.

“As a result, differences observed in the study between suicide ideators and controls could be due to differences between one group with psychiatric disorders ― the ideators ― and one group without such disorders ― the controls.”

Like Dr Brent, Dr Klonsky also found the ability of the machine-learning approach to distinguish suicidal ideators who had attempted suicide from those who had not was “the most exciting” finding.

“Most commonly cited risk factors for suicide, such as depression and hopelessness, are strong correlates of suicidal ideation but are poor predictors of attempts among ideators. If the study’s technique can illuminate differences between attempters and ideators, that could advance both suicide theory and prevention.”

The research was partially supported by the National Institute of Mental Health and an Endowed Chair in Suicide Studies at the University of Pittsburgh School of Medicine. The study authors and Dr Klonsky have disclosed no relevant financial relationships.

Nat Hum Behav. Published online October 30, 2017. Abstract

#Suicide attempts 4-times higher in #young people with #chronic illness

Postado em

 

The findings suggest young people with chronic illness such as asthma and diabetes should be routinely assessed for suicidal risk.

Adolescents and young adults with a chronic illness are significantly more likely to engage in suicidal thoughts, plans and attempts, as compared with their healthy peers, according to researchers at the University of Waterloo in Canada.
More than 5,000 individuals between the ages of 15 and 30 years were involved in the study, of which almost a third had one or more chronic illness, such as asthma, arthritis, Crohn’s disease, diabetes or epilepsy.

The study, published in the Canadian Journal of Psychiatry , found that those with a chronic illness were 28 per cent more likely to have suicidal thoughts. They were also twice as likely to make suicidal plans and 4.6-times more likely to attempt suicide. The odds for suicidal thoughts were higher among individuals with chronic illness and a mood disorder, with that cohort being 89 per cent more likely to have suicidal thoughts.

These findings strengthen the current knowledge about the elevated odds for suicidal thoughts and behaviour (STB) among adolescents and young adults with chronic illness, as well as the differential effects for those with and without comorbid mood disorders, say the authors.

They suggest that health professionals should routinely ask about STB during assessments of adolescent and young adult patients with chronic illnesses.

Global action needed on suicide among health care workers, says Lancet editorial

Postado em

Experts say the rate of depressive disorders among health-care workers compared with the general population is “alarming”.

Global collaboration is needed to understand and tackle the deep-rooted underlying issues associated with mental ill health in the medical profession.

That is according to a new editorial published in The Lancet , which is highlighting fresh efforts in the USA to address the high suicide rate among doctors there. In the region of 400 doctors die by suicide in the US each year. Its National Academy of Medicine is collaborating with more than 20 professional and educational organisations to promote wellbeing and resilience among doctors. The platform, which is due to begin work this month, aims to assess and understand the underlying causes of clinician burnout and suicide and advance solutions that can reverse the current trends.

The Lancet editorial suggests lessons can be learned from this initiative, not just in the US but globally. “Now is not the time to become complacent or to let the health of medical workers slip down the political agenda, but to start 2017 by following a lead taken by the National Academy of Medicine: to ensure that the health and resilience of our medical workforce are the highest priorities in every country,” it states.

Study finds nightmares are linked to thoughts of suicide

Postado em

Bad dreams may act as a stressor in people with PTSD.

Nightmares and suicidal thoughts, plans or attempts are connected, according to a British study published in the “Journal of Clinical Sleep Medicine”. The reason, the authors suggest, lies in certain negative cognitive thoughts triggered by the dreams.

For the study, the researchers at the University of Manchester collected data from 91 participants who had experienced traumatic events. 51 of the subjects met criteria for post-traumatic stress disorder (PTSD) currently, and an additional 24 reported a prior diagnosis of PTSD. Frequency and intensity ratings of the nightmares were measured using a PTSD scale. Participants also completed questionnaire measures of suicidal behaviour, hopelessness, defeat, and entrapment.

The results show that suicidal thoughts, plans or attempts were present in 62 per cent of participants who experienced nightmares, but only in 20 per cent of those without nightmares.

Further analyses suggest that nightmares may act as a stressor in people with PTSD, triggering specific types of negative cognitive thoughts which reinforce suicidal thoughts and behaviours. The pathways between nightmares and suicidal behaviours appear to operate independent of comorbid insomnia and depression.

“PTSD increases the risk of suicidal thoughts and behaviour, and our study shows that nightmares, a hallmark symptom of PTSD, may be an important treatment target to reduce suicide risk,” said principal investigator Donna L. Littlewood. “This study emphasises the importance of specifically assessing and targeting nightmares within those individuals experiencing PTSD.”

Risks of aggression and suicide in children increase with antidepressants

Postado em

Danish researchers harshly criticise trial reports in which relevant information is often omitted.

The risk of aggression and suicide is twice as high in children and adolescents who take antidepressants. This is the result of a Danish meta-analysis published in “The BMJ”. Researchers were critical to the fact that essential information had been omitted from reports on clinical trials.

The team from the University of Copenhagen carried out a systematic review and meta-analysis of 68 clinical studies and 70 trials involving 18,526 patients. They focussed on associations between use of commonly-prescribed antidepressants – selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) – and serious adverse effects such as death, suicidal thoughts and attempts, aggression and akathisia.

The researchers found no association between suicide, aggression and use of antidepressants in adults. However, use of these medications doubled the risk of these adverse effects in children and adolescents.

It is unknown if this mirrors the true extent, however. Due to the poor design of many studies and misreporting of findings in published articles, antidepressant-related harm was often omitted from the reports. This is well-documented when comparing clinical trial reports with individual patient reports, the researchers said.

In particular, deaths and suicides are frequently misreported or not included in the analyses, and more than half of the suicide attempts or thoughts were described as “emotional lability” or “worsening of depression”. Individual reports of adverse outcomes for all patients were only available for 32 trials, criticised the authors. “The true risk for serious harm is still unknown because of the low incidence of these rare events, and the poor design and reporting of the trials makes it difficult to get accurate effect estimates”, wrote the experts.

In any case, the clinicians urged that children, adolescents and young adults limit the use of antidepressants to a minimum and switch to alternative treatment options. In addition, trials should be better planned and reports should be more comprehensive.